Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

Circulating anti-p53 antibodies have been described and used as tumoural markers in patients with various cancers and strongly correlate with the p53 mutated status of the tumours. No study has yet looked at the prevalence of such antibodies in skin carcinoma patients although these tumours have bee...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Moch, C, Moysan, A, Lubin, R, Salmonière, P de La, Soufir, N, Galisson, F, Vilmer, C, Venutolo, E, Pelletier, F Le, Janin, A, Basset-Séguin, N
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2001
Aiheet:
Regular Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364020/
https://ncbi.nlm.nih.gov/pubmed/11747330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2185
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia